Clinical Trials Logo

Intermediate Uveitis clinical trials

View clinical trials related to Intermediate Uveitis.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT01717170 Active, not recruiting - Posterior Uveitis Clinical Trials

Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study

STOP-Uveitis
Start date: March 2013
Phase: Phase 1/Phase 2
Study type: Interventional

In the STOP-UVEITIS study, we propose to evaluate the safety, tolerability, and bioactivity of two doses of Tocilizumab (4mg/kg and 8mg/kg), administered monthly, in patients with non-infectious intermediate, posterior, or panuveitis.